ARTICLE | Clinical News
Ozenoxacin 1% regulatory update
July 11, 2016 7:00 AM UTC
Medimetriks Pharmaceuticals Inc. (Fairfield, N.J.) submitted an NDA to FDA for ozenoxacin 1% cream to treat impetigo. In 2014, Ferrer granted Medimetriks exclusive commercialization rights to the ant...